StockData
SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SANUWAVE Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.83−0.13 (-2.62%)

Close on Oct 19, 2026

Market cap
$41.54M
P/E (TTM)
11.8
Dividend yield
–

SANUWAVE Health, Inc. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Consumables, parts, and accessories revenue$7.33M$6.64M––$6.51M$6.03M––––––75.2%+12.5%
System revenue$2.29M$2.88M$6.82M$4.39M$3.45M$3.20M$3.93M$3.66M$2.11M$1.37M––23.5%-33.6%
Extended warranty$78.00K$60.00K––$41.00K$38.00K––––––0.8%+90.2%
Other$48.00K$43.00K––$45.00K$64.00K––––––0.5%+6.7%
License fees$0$0––$10.00K$5.00K––––––0.0%-100.0%
System revenue–––––––$3.66M$2.11M$1.37M$2.06M$1.63M––
License fees and other–––$5.00K$10.00K$5.00K$10.00K$10.00K$15.00K$5.00K–$38.00K––
Consumables and parts revenue–––$7.03M$6.69M$6.09M$6.26M$5.62M$4.95M$4.31M$4.53M$3.16M––

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
United States––––$10.15M$9.33M$10.31M$9.33M$7.12M$5.64M$6.99M$4.91M––
International––––$16.00K$15.00K$16.00K$31.00K$46.00K$142.00K$7.00K$43.00K––

From the segment and revenue-disaggregation notes of SANUWAVE Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.